Palvella Gets Initial Proceeds From FDA Orphan Products Grant
9/6 19:22
(RTTNews) - Palvella Therapeutics Inc. (PVLA), a clinical-stage biopharmaceutical company, Monday it has received the initial proceeds from a previously announced grant from the FDA Office of Orphan Products Development....